Expanding the spectrum of IDH1 mutations in gliomas von Gupta, Ruta, Flanagan, Simon, Li, Cheryl CY, Lee, Maggie, Shivalingham, Brindha, Maleki, Sanaz, Wheeler, Helen R, Buckland, Michael E

Volltext

Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs) von Fogarty, Gerald, Dolven-Jacobsen, Kari, Morton, Rachael L., Hruby, George, Nowak, Anna K., Vardy, Janette L., Drummond, Katharine J., Dhillon, Haryana M., Mandel, Catherine, Scolyer, Richard A., Shivalingham, Brindha, Middleton, Mark R., Burmeister, Bryan H., Lo, Serigne, Reisse, Claudius H., Paton, Elizabeth J., Steel, Victoria, Williams, Narelle C., Thompson, John F., Hong, Angela M.

Volltext

Pharmacokinetic and pharmacodynamic analysis of preoperative therapy with dabrafenib alone and in combination with trametinib in patients with BRAF mutation–positive melanoma with... von Davies, Michael A., Tawbi, Hussein, Ouellet, Daniele, Lazar, Alexander J. F., Weinberg, Jeffrey S, Butterfield, Lisa H., Hamilton, Ronald L., Amankulor, Nduka, Engh, Johnathan A., Shivalingham, Brindha, Kefford, Richard, Scolyer, Richard A, Mahmood, Syed, Richards-Peterson, Lauren Elizabeth, Swann, Suzanne, Arbushites, Michael C., Long, Georgina V., Kirkwood, John M.

Volltext